ICH Q3B (R2) Impurities in new drug products
Table of contents
This document provides guidance on the content and qualification of impurities in new drug products for registration applications. It applies to drug products produced from chemically synthesised new drug substances not previously registered in a region or Member State.
Keywords: Finished product, impurities, reporting, control, qualification, specifications